MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Cognitive Function in Late-life and Parkinson’s Disease Neuropathology at Death

    R. Abbott, G. Ross, H. Petrovitch, K. Masaki, J. Uyehara-Lock, C. Tanner (Ansan-si, Republic of Korea)

    Objective: To examine the association between cognitive function in late-life and Parkinson’s disease (PD) neuropathology at death, including 1) neuron loss in the locus coeruleus…
  • 2022 International Congress

    Demographic and Regional Variation in All-Cause Mortality Rates among United States Medicare Beneficiaries with Parkinson’s Disease

    W. Aamodt, A. Willis, J. Farrar (Philadelphia, USA)

    Objective: To determine whether all-cause mortality rates among persons with Parkinson’s disease (PD) in the United States (US) differ by sex, race/ethnicity, or geographic location.…
  • 2022 International Congress

    Newly identified cases of parkinsonism and prodromal PD in a remote LRRK2 G2019S cohort

    J. Soto, S. Jensen-Roberts, T. Myers, M. Pawlik, E. Hartman, S. Lettenberger, A. Kaplan, R. Toor, R. Wilson, P. Auinger, E. Dorsey, B. Valdovinos, K. Amodeo, S. Sharma, R. Holloway, C. Tanner, R. Alcalay, R. Schneider (Rochester, USA)

    Objective: To evaluate new cases of prodromal PD and concern for parkinsonism in a cohort of LRRK2 G2019S carriers. Background: LRRK2 G2019S is a common…
  • 2022 International Congress

    Bis(monoacylglycerol) phosphate levels are elevated at baseline in carriers of pathogenic variants in LRRK2 and GBA1 and do not predict progression of PD in PPMI cohorts

    K. Merchant, T. Simuni, J. Fedler, M. Brumm, C. Caspell, E. Tangstrandt, F. Hsieh, K. Nudelman, T. Foroud, C. Coffey, A. Siderowf, C. Tanner, K. Marek, P. Investigators (Chicago, USA)

    Objective: To assess: (a) effects of LRRK2 and GBA1 pathogenic variants on baseline urinary bis(monoacylglycerol) phosphate (BMP) levels in those with and without Parkinson’s disease…
  • 2022 International Congress

    Longitudinal combined 11C UCB J and 18F FE PE2I PET imaging of presynaptic terminal loss in early Parkinson’s disease.

    A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To longitudinally assess presynaptic terminal loss in vivo over a 2-year period in people with early Parkinson’s disease (PD). Background: Imaging tools that allow…
  • 2022 International Congress

    Use of a wearable medical device for LCIG tube adjustment: a user case

    JHR. Herreros Rodríguez, AEL. Esquivel López, JP. Romero Muñoz, M. Llaguno Velasco (Madrid, Spain)

    Objective: To identify objectively the change in motor symptoms in a patient with Parkinson’s Disease (PD) on levodopa-carbidopa intestinal gel (LCIG) treatment with and without…
  • 2022 International Congress

    Remote Assessment of Tremor using Wearable Sensors in Parkinson’s Disease Research

    M. Pawlik, K. Dinesh, S. Jensen-Roberts, E. Waddell, T. Myers, J. Soto, E. Hartman, E. Nnadika, P. Yang, R. Yuan, G. Sharma, R. Wilson, K. Lizarraga, C. Tarolli, R. Schneider, R. Dorsey, J. Adams (Rochester, USA)

    Objective: To describe wearable sensor-derived measures in Parkinson’s disease (PD) research. Background: Many commonly used outcome measures of PD are subjective, rater dependent, and infrequently…
  • 2022 International Congress

    Is motor symptoms asymmetry a possible predictor of short-term motor outcome of bilateral STN-DBS in Parkinson’s disease?

    F. Cavallieri, F. Bove, A. Castrioto, S. Meoni, E. Schmitt, A. Bichon, A. Kistner, P. Pélissier, E. Lhommée, E. Chevrier, S. Chabardès, E. Seigneuret, V. Fraix, E. Moro (Reggio Emilia, Italy)

    Objective: To evaluate if the body side of motor symptoms onset may predict the short-term motor outcome of bilateral subthalamic nucleus deep brain stimulation (STN-DBS)…
  • 2022 International Congress

    Synaptic Zn2+ Contribution to Parkinson’s Disease Pathophysiology: Pharmacological & Genetic Studies in Preclinical Mouse Models

    AM. Ouagazzal, J. Sikora (Marseille, France)

    Objective: The potential involvement of synaptic Zn2+ in development of Parkinson’s disease (PD) motor symptoms and dopaminergic neurodegeneration was investigated. Background: The progressive degeneration of…
  • 2022 International Congress

    The relationship between cognitive function, fear of falling, and history of fall in people with Parkinson’s disease

    H. Khalil, A. Al-Sharman, R. Rehan, N. Alissa, A. Aburub, K. El-Salem (Doha, Qatar)

    Objective: The main aim of this study was to investigate the relationship of cognitive function with fear of falling (FOF) and falls in people with…
  • « Previous Page
  • 1
  • …
  • 299
  • 300
  • 301
  • 302
  • 303
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley